Lixisenatide, Glulisine Beneficial As Add-On to Basal Insulin
Men who sleep too much, too little may have impaired insulin sensitivity

Neoadjuvant endocrine therapy “a reasonable option” for ER-positive breast cancer

05 Jul 2016

A meta-analysis of 3490 patients published in JAMA Oncology compared the pros and cons of neoadjuvant endocrine therapy, even as a monotherapy, to combination chemotherapy.

News Medical

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read